Cell survival and death in oxidant lung injury
Cell survival and death in oxidant lung injury
批准号:
8279197
负责人:
Michael A O'Reilly
金额:
$38.63万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2002
资助国家:
美国
项目状态:
已结题
起止时间:
2002-07-01 至 2015-04-30
关键词:
A549AdolescentAdultAgeAirAlveolarApoptoticBackBirthBlood PressureBronchopulmonary DysplasiaCartoonsCell CycleCell Cycle ArrestCell DeathCell Differentiation processCell LineCell NucleusCell SurvivalCellsChild MortalityChronicCleaved cellDNADNA DamageDisease AttributesEnvironmental air flowEnzymesEpithelialEpithelial Cell ProliferationEpithelial CellsEpitheliumExposure toFunctional disorderGene ExpressionGenesGeneticGoalsGrowthHyperoxiaLeadLongevityLungLung diseasesMitochondriaMitochondrial DNAMitochondrial DiseasesModelingMusMuscleNeonatalNeuronsNewborn InfantNuclearOxidantsOxygenOxygen measurement, partial pressure, arterialPhosphorylationPredispositionProtein p53Pulmonary HypertensionRespirationRespiratory physiologyRetroviridaeRisk FactorsSerineSignal PathwaySignal TransductionStructure of respiratory epitheliumTestingTherapeutic UsesTimeTissuesTransgenic MiceTumor Suppressor ProteinsVirus Diseasesage relatedagedbasecell growthinhibitor/antagonistlung developmentlung injurymitochondrial dysfunctionmitochondrial genomeneonatenovelnovel therapeuticsoxidative damageoxygen toxicitypostnatalprematurerespiratoryresponserestriction enzymesurfactant
中文摘要
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION (provided by applicant): Premature exposure to oxygen is a major risk factor for bronchopulmonary dysplasia (BPD), a chronic form of lung disease frequently seen in neonates that is characterized as an arrest in lung development. Although the therapeutic use of exogenous surfactant and milder ventilation strategies has reduced mortality, children and adolescents born prematurely have reduced lung function, increased susceptibility to respiratory viral infections, and age-associated increases in blood pressure. Hence there is an urgent need to understand how oxygen permanently disrupts growth of the developing lung. Recent studies suggest damage to mitochondria is a component of oxygen-induced newborn lung disease because elevated levels of oxygen (hyperoxia) suppress mitochondrial respiration and damage mitochondrial DNA. To determine whether cells activate retrograde signaling back to the nucleus to control gene expression in response to mitochondrial DNA damage, epithelial cells were infected with retroviruses expressing enzymes that cause strand breaks in mitochondrial or nuclear DNA. Like hyperoxia, damage to mitochondrial or nuclear DNA stimulated expression of the tumor suppressor protein p53. In contrast, mitochondrial targeting of an enzyme that only cuts nuclear DNA failed to activate p53, but did so when targeted to the nucleus. When activated by mitochondrial DNA damage, p53 stimulated expression of nuclear genes that inhibited cell growth and enhanced cell survival. These findings suggest the cell reacts to mitochondrial DNA damage with a classic nuclear DNA damage response, and that this response inhibits cell growth, perhaps in anticipation of impending mitochondrial dysfunction and energy depletion. Based upon these findings, we now propose to test the hypothesis that mitochondrial DNA damage is a component of how hyperoxia activates p53 signaling and disrupts postnatal lung development. We will test this hypothesis using novel retroviruses and transgenic mice capable of conditionally damaging mitochondrial DNA in respiratory epithelial cells. Understanding how cells respond specifically to oxygen-induced mitochondrial DNA damage is highly significant because it could lead to new therapeutic opportunities for reducing oxygen-toxicity to the developing lung as well as age-related diseases attributed to oxygen toxicity.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Role of early life hyperoxia on mesenchymal stem cell fate: their impact on age related disease
-
批准号:10475250
-
项目类别:
-
资助金额:$19.25万
-
财政年份:2021
-
负责人:Michael A O'Reilly
-
依托单位:
Role of early life hyperoxia on mesenchymal stem cell fate: their impact on age related disease
-
批准号:10312537
-
项目类别:
-
资助金额:$23.1万
-
财政年份:2021
-
负责人:Michael A O'Reilly
-
依托单位:
Effect of Neonatal Hyperoxia on Alveolar Development and Infection
-
批准号:9172674
-
项目类别:
-
资助金额:$11.51万
-
财政年份:2008
-
负责人:Michael A O'Reilly
-
依托单位:
Effect of Neonatal Hyperoxia on Alveolar Development and Infection
-
批准号:9000732
-
项目类别:
-
资助金额:$38.38万
-
财政年份:2008
-
负责人:Michael A O'Reilly
-
依托单位:
Effect of Neonatal Hyperoxia on Alveolar Development and Infection
-
批准号:10001048
-
项目类别:
-
资助金额:$53.66万
-
财政年份:2008
-
负责人:Michael A O'Reilly
-
依托单位:
Effect of Neonatal Hyperoxia on Alveolar Development and Infection
-
批准号:7591323
-
项目类别:
-
资助金额:$38.5万
-
财政年份:2008
-
负责人:Michael A O'Reilly
-
依托单位:
Effect of Neonatal Hyperoxia on Alveolar Development and Infection
-
批准号:8630581
-
项目类别:
-
资助金额:$38.38万
-
财政年份:2008
-
负责人:Michael A O'Reilly
-
依托单位:
Effect of Neonatal Hyperoxia on Alveolar Development and Infection
-
批准号:9767838
-
项目类别:
-
资助金额:$53.66万
-
财政年份:2008
-
负责人:Michael A O'Reilly
-
依托单位:
Effect of Neonatal Hyperoxia on Alveolar Development and Infection
-
批准号:10246362
-
项目类别:
-
资助金额:$53.66万
-
财政年份:2008
-
负责人:Michael A O'Reilly
-
依托单位:
Effect of Neonatal Hyperoxia on Alveolar Development and Infection
-
批准号:8197382
-
项目类别:
-
资助金额:$38.12万
-
财政年份:2008
-
负责人:Michael A O'Reilly
-
依托单位:
Effect of Neonatal Hyperoxia on Alveolar Development and Infection
-
批准号:7746428
-
项目类别:
-
资助金额:$38.5万
-
财政年份:2008
-
负责人:Michael A O'Reilly
-
依托单位:
Effect of Neonatal Hyperoxia on Alveolar Development and Infection
-
批准号:7989991
-
项目类别:
-
资助金额:$38.5万
-
财政年份:2008
-
负责人:Michael A O'Reilly
-
依托单位:
Core--Instrumentation Facility
-
批准号:6867266
-
项目类别:
-
资助金额:$17.65万
-
财政年份:2005
-
负责人:Michael A O'Reilly
-
依托单位:
DNA Repair and Replication in Oxidant Lung Injury
-
批准号:6924577
-
项目类别:
-
资助金额:$35.44万
-
财政年份:2002
-
负责人:Michael A O'Reilly
-
依托单位:
DNA Repair and Replication in Oxidant Lung Injury
-
批准号:6756459
-
项目类别:
-
资助金额:$35.44万
-
财政年份:2002
-
负责人:Michael A O'Reilly
-
依托单位:
Cell survival and death in oxidant lung injury
-
批准号:8661214
-
项目类别:
-
资助金额:$37.85万
-
财政年份:2002
-
负责人:Michael A O'Reilly
-
依托单位:
DNA Repair and Replication in Oxidant Lung Injury
-
批准号:6508966
-
项目类别:
-
资助金额:$35.44万
-
财政年份:2002
-
负责人:Michael A O'Reilly
-
依托单位:
Cell Survival and Death in Oxidant Lung Injury
-
批准号:7266475
-
项目类别:
-
资助金额:$38.5万
-
财政年份:2002
-
负责人:Michael A O'Reilly
-
依托单位:
Cell survival and death in oxidant lung injury
-
批准号:8468006
-
项目类别:
-
资助金额:$36.77万
-
财政年份:2002
-
负责人:Michael A O'Reilly
-
依托单位:
Cell Survival and Death in Oxidant Lung Injury
-
批准号:7388820
-
项目类别:
-
资助金额:$38.5万
-
财政年份:2002
-
负责人:Michael A O'Reilly
-
依托单位:
海外基金